Haemodynamic effects of patent foramen ovale and atrial septal defect closure: a comparison during percutaneous shunt closure

被引:4
|
作者
Luermans, Justin G. L. M. [1 ]
Bos, Willem J. W. [2 ]
Post, Martijn C. [1 ]
ten Berg, Jurrien M. [1 ]
Plokker, H. W. Thijs [1 ]
Suttorp, Maarten J. [1 ]
机构
[1] St Antonius Hosp, Dept Cardiol, NL-3435 CM Nieuwegein, Netherlands
[2] St Antonius Hosp, Dept Internal Med, NL-3435 CM Nieuwegein, Netherlands
关键词
atrial septal defect; Finometer; haemodynamics; patent foramen ovale; transcatheter closure; TRANSCATHETER CLOSURE; ARTERIAL-PRESSURE; FINGER; HUMANS; FLOW;
D O I
10.1111/j.1475-097X.2009.00905.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
P>Objectives: We investigated the haemodynamic effect of percutaneous closure of an intra-atrial shunt, using non-invasive finger pressure measurements. Background: Percutaneous closure of both patent foramen ovale (PFO) and atrial septal defect (ASD) is widely practised. Currently no data are available on short-term haemodynamic changes induced by closure. Methods: Twenty-five consecutive patients (mean age 49 +/- 17 years, 10 men) who underwent a percutaneous closure of a PFO (n = 15) or ASD (n = 10) were included in this study. During the procedure blood pressure and heart rate (HR) were monitored continuously with a Finometer (R). Changes in systolic, mean, and diastolic pressure, stroke volume (SV), cardiac output (CO) and total peripheral resistance (TPR) were computed from the pressure registrations using Modelflow (R) methodology. Results: Baseline characteristics were similar for the PFO and ASD patients. After PFO closure none of the haemodynamic parameters changed significantly. After ASD closure the systolic, mean, and diastolic pressures increased 7 center dot 1 +/- 5 center dot 4 (P = 0 center dot 003), 3 center dot 8 +/- 3 center dot 5 (P = 0 center dot 007) and 2 center dot 0 +/- 3 center dot 0 mmHg (P = ns) respectively. HR decreased 5 center dot 1 +/- 5 center dot 3 beats per minute (P = 0 center dot 01). SV, CO and TPR increased 8 center dot 5 +/- 6 center dot 4 ml (13 center dot 5%; P = 0 center dot 002), 0 center dot 21 +/- 0 center dot 45 l min-1 (5 center dot 6%; P = ns) and 0 center dot 02 +/- 0 center dot 14 dynes (4 center dot 1%; P = ns) respectively. The changes in SV differ between the PFO and ASD patients (P = 0 center dot 009). Conclusions: Using non-invasive finger pressure measurements, we found that SV, mean and systolic blood pressure increased immediately after percutaneous closure of an ASD in adults, whereas the percutaneous PFO closure had no effect on haemodynamic characteristics.
引用
收藏
页码:64 / 68
页数:5
相关论文
共 50 条
  • [31] Atrial Fibrillation After Percutaneous Patent Foramen Ovale Closure
    Mojadidi, Mohammad K.
    Elgendy, Akram Y.
    Elgendy, Islam Y.
    Mahmoud, Ahmed N.
    Meier, Bernhard
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 122 (05): : 915 - 915
  • [32] Transcatheter Closure of Patent Foramen Ovale in A Patient with Aneurysmal Atrial Septum and Multifenestrated Atrial Septal Defect
    Khajali, Zahra
    Firouzi, Ata
    Nazari, Mohamad Sadra
    Hedayati, Maryam Keshavarz
    Jorfi, Fateme
    Alizadehasl, Azin
    Zohrian, Fatemeh
    INTERNATIONAL CARDIOVASCULAR RESEARCH JOURNAL, 2020, 14 (04) : 157 - 160
  • [33] Percutaneous patent Foramen ovale and atrial septal defect closure in adults: Results and device comparison in 100 consecutive implants at a single center
    Herrmann, HC
    Silvestry, FE
    Glaser, R
    See, V
    Kasner, S
    Bradbury, D
    Chang, G
    Hirshfeld, JW
    Horwitz, PA
    Kelly, M
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 64 (02) : 197 - 203
  • [34] Percutaneous closure of patent foramen ovale using the HELEX septal occluder
    Reschke, M
    Ostermayer, S
    Büscheck, F
    Bayard, Y
    Billinger, K
    Trepels, T
    Sievert, H
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 13L - 13L
  • [35] Percutaneous Atrial Septal Defect Or Patent Foramen Ovale Closure Guided By Intracardiac Ultrasound Comparison With Transesophageal Ultrasound Findings Before The Procedure
    Vavuranakis, Manolis
    Kavouras, Charalambos
    Vlaseros, Ioannis
    Vaina, Sophia
    Papaioannou, Theodoros
    Sanidas, Elias
    Stefanadis, Christodoulos
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 28D - 28D
  • [36] Results of Percutaneous Closure of Patent Foramen Ovale With the GORE® Septal Occluder
    Knerr, Meike
    Bertog, Stefan
    Vaskelyte, Laura
    Hofmann, Ilona
    Sievert, Horst
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2014, 83 (07) : 1144 - 1151
  • [37] Intracardiac ultrasound imaging during percutaneous atrial septal defect or patent foramen ovale closure. Comparison with transesophageal ultrasound findings before the procedure
    Vavouranakis, M.
    Kavouras, C.
    Vlasseros, I.
    Vaina, S.
    Papaioannou, T.
    Sanidas, E.
    Speggos, K.
    Flessas, D.
    Kalikazaros, I.
    Stefanadis, C.
    EUROPEAN HEART JOURNAL, 2009, 30 : 395 - 395
  • [38] PREDICTORS OF RESIDUAL SHUNT FOLLOWING PERCUTANEOUS PATENT FORAMEN OVALE CLOSURE
    Brown, Kristen
    Haynatzki, Gleb
    Goldsweig, Andrew Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 869 - 869
  • [39] Adverse events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent Foramen ovale closure
    Wertman, B
    Azarbal, B
    Riedl, M
    Tobis, J
    CIRCULATION, 2005, 112 (17) : U755 - U755
  • [40] Safety and efficacy of biostar bioadsorbable atrial septal device for percutaneous patent foramen ovale closure
    Gioffre, G.
    Iamele, M.
    Giardina, A.
    Licitra, R.
    Rossi, S.
    Befani, L.
    Stefanini, G.
    Pendenza, G.
    Iani, C.
    Gaspardone, A.
    EUROPEAN HEART JOURNAL, 2009, 30 : 392 - 392